Reflection Biotechnologies (ReflectionBio®) is a patient-driven biotech company. Founded by a rare disease patient, we apply the “By Patients, For Patients” approach for patients to combine efforts in driving #RareDisease and #OrphanDrug R&D. We focus on developing gene therapy and other novel treatments for rare diseases which currently have no or few treatment options available.